SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-006229
Filing Date
2018-09-14
Accepted
2018-09-14 16:08:47
Documents
6
Period of Report
2018-10-25
Effectiveness Date
2018-09-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2236632zdef14a.htm DEF 14A 751630
2 G460485.JPG g460485.jpg GRAPHIC 13363
3 G316290.JPG g316290.jpg GRAPHIC 3705
4 G893572.JPG g893572.jpg GRAPHIC 5930
5 G200132BCI001.GIF g200132bci001.gif GRAPHIC 247961
6 G200132BCI002.GIF g200132bci002.gif GRAPHIC 186147
  Complete submission text file 0001047469-18-006229.txt   1382573
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-16633 | Film No.: 181071220
SIC: 2834 Pharmaceutical Preparations